This old version of Proteopedia is provided for student assignments while the new version is undergoing repairs. Content and edits done in this old version of Proteopedia after March 1, 2026 will eventually be lost when it is retired in about June of 2026.
Apply for new accounts at the new Proteopedia. Your logins will work in both the old and new versions.
Search results
From Proteopedia
You searched for Downing,_K.H.
There is no page with the exact title "Downing,_K.H.". The search results for "Downing,_K.H." are displayed below. You can create a page titled Downing,_K.H. (by clicking on the red link).
For more information about searching Proteopedia, see Help.
To exclude pages titled with 4-character PDB codes, use the checkbox "only Human created pages" at the bottom of this page.
Showing below up to 20 results starting with #1.
View (previous 20) (next 20) (20 | 50 | 100 | 250 | 500)
Article title matches
- Category:Downing KH (41 bytes)
1: List of pages with the keyword Downing KH - Category:Downing, K H. (44 bytes)
1: List of pages with the keyword Downing, K H. - Category:Downing, A K (43 bytes)
1: List of pages with the keyword Downing, A K - Category:Downing, K H (43 bytes)
1: List of pages with the keyword Downing, K H - Category:Downing, M E (43 bytes)
1: List of pages with the keyword Downing, M E - Category:Downing, D M (43 bytes)
1: List of pages with the keyword Downing, D M - Category:Downing AK (41 bytes)
1: List of pages with the keyword Downing AK - Category:Downing ME (41 bytes)
1: List of pages with the keyword Downing ME
Page text matches
- 1emo (8,056 bytes)
2: ...F A PAIR OF FIBRILLIN CA2+ BINDING EPIDERMAL GROWTH FACTOR-LIKE DOMAINS, 22 STRUCTURES==
3: <StructureSection load='1emo' size='340' side='right'caption='[[1emo]]' scene=''>
4: == Structural highlights ==
5: ...mponents</b> use [https://proteopedia.org/fgij/fg.htm?mol=1EMO FirstGlance]. <br>
6: ...ls|Method:]]</b></td><td class="sblockDat" id="methodDat">Solution NMR</td></tr> - 1emn (8,070 bytes)
2: ...F A PAIR OF FIBRILLIN CA2+ BINDING EPIDERMAL GROWTH FACTOR-LIKE DOMAINS, MINIMIZED AVERAGE STRUCTURE=...
3: <StructureSection load='1emn' size='340' side='right'caption='[[1emn]]' scene=''>
4: == Structural highlights ==
5: ...mponents</b> use [https://proteopedia.org/fgij/fg.htm?mol=1EMN FirstGlance]. <br>
6: ...ls|Method:]]</b></td><td class="sblockDat" id="methodDat">Solution NMR</td></tr> - 1hj7 (4,317 bytes)
2: ... pair of LDL receptor Ca2+ binding epidermal growth factor-like domains, 20 structures==
3: ...on load='1hj7' size='340' side='right'caption='[[1hj7]]' scene=''>
4: == Structural highlights ==
5: .../b> use [https://proteopedia.org/fgij/fg.htm?mol=1HJ7 FirstGlance]. <br>
6: ...ls|Method:]]</b></td><td class="sblockDat" id="methodDat">Solution NMR</td></tr> - 1apj (7,931 bytes)
2: ==NMR STUDY OF THE TRANSFORMING GROWTH FACTOR BETA BINDING PROTEIN-LIKE DOMAIN (TB MODUL...
3: <StructureSection load='1apj' size='340' side='right'caption='[[1apj]]' scene=''>
4: == Structural highlights ==
5: ...mponents</b> use [https://proteopedia.org/fgij/fg.htm?mol=1APJ FirstGlance]. <br>
6: ...ls|Method:]]</b></td><td class="sblockDat" id="methodDat">Solution NMR</td></tr> - 1ksq (3,151 bytes)
2: ...the Third TB Domain from Latent Transforming Growth Factor-beta Binding Protein-1==
3: <StructureSection load='1ksq' size='340' side='right'caption='[[1ksq]]' scene=''>
4: == Structural highlights ==
5: ...mponents</b> use [https://proteopedia.org/fgij/fg.htm?mol=1KSQ FirstGlance]. <br>
6: ...ls|Method:]]</b></td><td class="sblockDat" id="methodDat">Solution NMR</td></tr> - 1lmj (8,133 bytes)
2: ...-1 cbEGF12-13 Pair of Ca2+ Binding Epidermal Growth Factor-like Domains==
3: <StructureSection load='1lmj' size='340' side='right'caption='[[1lmj]]' scene=''>
4: == Structural highlights ==
5: ...mponents</b> use [https://proteopedia.org/fgij/fg.htm?mol=1LMJ FirstGlance]. <br>
6: ...ls|Method:]]</b></td><td class="sblockDat" id="methodDat">Solution NMR</td></tr> - 1toz (3,754 bytes)
2: ==NMR structure of the human NOTCH-1 ligand binding region==
3: <StructureSection load='1toz' size='340' side='right'caption='[[1toz]]' scene=''>
4: == Structural highlights ==
5: ...mponents</b> use [https://proteopedia.org/fgij/fg.htm?mol=1TOZ FirstGlance]. <br>
6: ...ls|Method:]]</b></td><td class="sblockDat" id="methodDat">Solution NMR</td></tr> - 1tpg (2,937 bytes)
2: ...UE-TYPE PLASMINOGEN ACTIVATOR (T-PA) (NMR, 298K, PH2.95, REPRESENTATIVE STRUCTURE)==
3: <StructureSection load='1tpg' size='340' side='right'caption='[[1tpg]]' scene=''>
4: == Structural highlights ==
5: ...mponents</b> use [https://proteopedia.org/fgij/fg.htm?mol=1TPG FirstGlance]. <br>
6: ...ls|Method:]]</b></td><td class="sblockDat" id="methodDat">Solution NMR</td></tr> - 1tpm (2,991 bytes)
2: ... TISSUE-TYPE PLASMINOGEN ACTIVATOR DETERMINED BY 1H NUCLEAR MAGNETIC RESONANCE==
3: <StructureSection load='1tpm' size='340' side='right'caption='[[1tpm]]' scene=''>
4: == Structural highlights ==
5: ...mponents</b> use [https://proteopedia.org/fgij/fg.htm?mol=1TPM FirstGlance]. <br>
6: ...ls|Method:]]</b></td><td class="sblockDat" id="methodDat">Solution NMR</td></tr> - 1tpn (2,991 bytes)
2: ... TISSUE-TYPE PLASMINOGEN ACTIVATOR DETERMINED BY 1H NUCLEAR MAGNETIC RESONANCE==
3: <StructureSection load='1tpn' size='340' side='right'caption='[[1tpn]]' scene=''>
4: == Structural highlights ==
5: ...mponents</b> use [https://proteopedia.org/fgij/fg.htm?mol=1TPN FirstGlance]. <br>
6: ...ls|Method:]]</b></td><td class="sblockDat" id="methodDat">Solution NMR</td></tr> - 1u5m (13,608 bytes)
2: ==Structure of a Chordin-like Cysteine-rich Repeat (VWC module) from Collagen IIA==
3: <StructureSection load='1u5m' size='340' side='right'caption='[[1u5m]]' scene=''>
4: == Structural highlights ==
5: ...mponents</b> use [https://proteopedia.org/fgij/fg.htm?mol=1U5M FirstGlance]. <br>
6: ...ls|Method:]]</b></td><td class="sblockDat" id="methodDat">Solution NMR</td></tr> - 2fs4 (5,370 bytes)
2: ...perazine-Based Renin Inhibitors: Optimization of the C ring==
3: <StructureSection load='2fs4' size='340' side='right'caption='[[2fs4]], [[Resolution|resolution]] 2.2...
4: == Structural highlights ==
5: ...mponents</b> use [https://proteopedia.org/fgij/fg.htm?mol=2FS4 FirstGlance]. <br>
6: ...XY}METHYL)-1-(4-{3-[(2-METHOXYBENZYL)OXY]PROPOXY}PHENYL)PIPERAZIN-2-ONE'>PZ1</scene></td></tr> - 2g1n (5,262 bytes)
2: ...perazine-based renin inhibitors: Optimization of the "C" ring==
3: <StructureSection load='2g1n' size='340' side='right'caption='[[2g1n]], [[Resolution|resolution]] 2.9...
4: == Structural highlights ==
5: ...mponents</b> use [https://proteopedia.org/fgij/fg.htm?mol=2G1N FirstGlance]. <br>
6: ...THYL-3-OXO-2,3-DIHYDRO-4H-1,4-BENZOTHIAZIN-4-YL]ETHYL}ACETAMIDE'>1IG</scene>, <scene name='pdbligand=... - 2g1o (5,241 bytes)
2: ...perazine-Based Renin Inhibitors: Optimization of the "C" Ring==
3: <StructureSection load='2g1o' size='340' side='right'caption='[[2g1o]], [[Resolution|resolution]] 2.7...
4: == Structural highlights ==
5: ...mponents</b> use [https://proteopedia.org/fgij/fg.htm?mol=2G1O FirstGlance]. <br>
6: ...me='pdbligand=2IG:6-ETHYL-5-[9-(3-METHOXYPROPYL)-9H-CARBAZOL-2-YL]PYRIMIDINE-2,4-DIAMINE'>2IG</scene>... - 2g1r (5,335 bytes)
2: ...perazine-Based Renin Inhibitors: Optimization of the C Ring==
3: <StructureSection load='2g1r' size='340' side='right'caption='[[2g1r]], [[Resolution|resolution]] 2.4...
4: == Structural highlights ==
5: ...mponents</b> use [https://proteopedia.org/fgij/fg.htm?mol=2G1R FirstGlance]. <br>
6: ...METHYL-3-OXO-2,3-DIHYDRO-4H-1,4-BENZOXAZIN-4-YL]ETHYL}ACETAMIDE'>3IG</scene>, <scene name='pdbligand=... - 2g1s (5,335 bytes)
2: ...perazine-Based Renin Inhibitors: Optimization of the C Ring==
3: <StructureSection load='2g1s' size='340' side='right'caption='[[2g1s]], [[Resolution|resolution]] 2.5...
4: == Structural highlights ==
5: ...mponents</b> use [https://proteopedia.org/fgij/fg.htm?mol=2G1S FirstGlance]. <br>
6: ...OPHENYL)-4-(3-METHOXYPROPYL)-2H-1,4-BENZOXAZIN-3(4H)-ONE'>4IG</scene>, <scene name='pdbligand=NAG:N-A... - 2g1y (5,322 bytes)
2: ...perazine-Based Renin Inhibitors: Optimization of the "C" Ring==
3: <StructureSection load='2g1y' size='340' side='right'caption='[[2g1y]], [[Resolution|resolution]] 2.5...
4: == Structural highlights ==
5: ...mponents</b> use [https://proteopedia.org/fgij/fg.htm?mol=2G1Y FirstGlance]. <br>
6: ...-METHOXYPROPYL)-2,2-DIMETHYL-2H-1,4-BENZOXAZIN-3(4H)-ONE'>5IG</scene>, <scene name='pdbligand=NAG:N-A... - 2g20 (5,319 bytes)
2: ...perazine-Based Renin Inhibitors: Optimization of the C Ring==
3: <StructureSection load='2g20' size='340' side='right'caption='[[2g20]], [[Resolution|resolution]] 2.4...
4: == Structural highlights ==
5: ...mponents</b> use [https://proteopedia.org/fgij/fg.htm?mol=2G20 FirstGlance]. <br>
6: ...)-CYCLOHEX-3-EN-1-YLMETHYL]-2,3-DIHYDROXY-5-METHYLHEXYL}-L-ALANINAMIDE'>L1A</scene></td></tr> - 2g21 (5,228 bytes)
2: ...perazine-Based Renin Inhibitors: Optimization of the "C" Ring==
3: <StructureSection load='2g21' size='340' side='right'caption='[[2g21]], [[Resolution|resolution]] 2.2...
4: == Structural highlights ==
5: ...mponents</b> use [https://proteopedia.org/fgij/fg.htm?mol=2G21 FirstGlance]. <br>
6: ...L1B:7-(2,4-DIAMINO-6-ETHYLPYRIMIDIN-5-YL)-1-(3-METHOXYPROPYL)QUINOLINIUM'>L1B</scene></td></tr> - 2g22 (5,330 bytes)
2: ...perazine-Based Renin Inhibitors: Optimization of the "C" Ring==
3: <StructureSection load='2g22' size='340' side='right'caption='[[2g22]], [[Resolution|resolution]] 2.5...
4: == Structural highlights ==
5: ...mponents</b> use [https://proteopedia.org/fgij/fg.htm?mol=2G22 FirstGlance]. <br>
6: ...-1,2,3,4-TETRAHYDROQUINOLIN-7-YL]-N~4~-(2-PHENYLETHYL)PYRIMIDINE-2,4-DIAMINE'>6IG</scene>, <scene nam...
View (previous 20) (next 20) (20 | 50 | 100 | 250 | 500)
You may also try
